In the present study, miR-34a inhibited the expression of two genes promoting cell proliferation (sirt1 and cyclin D1); however, it also downregulated two genes (per2 and rev-erbα) with tumour suppressor capacity [40–43,102,103]; respectively). The gene discussed is SIRT1; the disease is neoplasm.